Insider Selling: Danaher Co. (NYSE:DHR) Director Sells 708 Shares of Stock

Danaher Co. (NYSE:DHR - Get Free Report) Director Alan G. Spoon sold 708 shares of Danaher stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the sale, the director now directly owns 116,202 shares in the company, valued at $28,304,483.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Danaher Price Performance

NYSE DHR opened at $248.38 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The company has a market capitalization of $183.97 billion, a price-to-earnings ratio of 42.10, a PEG ratio of 3.80 and a beta of 0.83. The stock has a 50-day moving average of $248.59 and a 200 day moving average of $232.00. Danaher Co. has a one year low of $182.09 and a one year high of $259.00.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.72 by $0.20. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm's revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.36 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend


The most important AI company you've never heard of
Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.
Get the full story on this secret AI company poised for massive growth


The company also recently announced a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Thursday, March 28th were issued a $0.27 dividend. This is an increase from Danaher's previous quarterly dividend of $0.24. The ex-dividend date was Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.43%. Danaher's dividend payout ratio is currently 18.31%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Royal Bank of Canada lifted their price target on Danaher from $254.00 to $282.00 and gave the company an "outperform" rating in a research report on Wednesday, January 31st. StockNews.com cut shares of Danaher from a "buy" rating to a "hold" rating in a report on Wednesday, January 31st. KeyCorp increased their price target on shares of Danaher from $260.00 to $290.00 and gave the stock an "overweight" rating in a research note on Thursday, February 1st. TD Cowen boosted their price objective on shares of Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a research note on Wednesday, April 24th. Finally, Citigroup upped their price objective on shares of Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a report on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average target price of $267.31.

View Our Latest Analysis on Danaher

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of DHR. Norges Bank purchased a new position in shares of Danaher in the fourth quarter worth approximately $1,752,382,000. Wellington Management Group LLP boosted its stake in shares of Danaher by 18.6% during the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate's stock worth $6,185,203,000 after acquiring an additional 3,905,449 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in shares of Danaher by 214.4% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 3,073,661 shares of the conglomerate's stock valued at $711,051,000 after acquiring an additional 2,096,038 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of Danaher by 10.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,757,558 shares of the conglomerate's stock worth $3,876,694,000 after purchasing an additional 1,619,586 shares in the last quarter. Finally, Capital International Investors raised its holdings in Danaher by 9.1% in the 4th quarter. Capital International Investors now owns 15,956,519 shares of the conglomerate's stock worth $3,691,735,000 after purchasing an additional 1,334,781 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Danaher?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Danaher and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles